Nov 30, 2022
Common chemotherapy drug could carry toxic inheritance for future generations of cancer survivors
A common chemotherapy drug could carry a toxic inheritance for children and grandchildren of adolescent cancer survivors, Washington ...
Nov 29, 2022
Data Support Whole Brain Irradiation Reduction in Pediatric Cancer Survivors
Results from a pooled case control study indicate that meninges are very radiosensitive in pediatric patients who were treated at prior ...
Nov 18, 2022
Diet High in Sugar May Accelerate Aging in Survivors of Childhood Cancer
High sugar consumption may increase age-related health conditions in survivors of childhood cancer, explained study authors at the AACR ...
Nov 15, 2022
World-first clinical trial in ‘man’s best friend’ could unlock breakthrough for kids with cancer
Telethon Kids Institute is leading a unique clinical trial in pet dogs that could pave the way for a new immunotherapy treatment for one...
Nov 14, 2022
Altered cell behavior behind resistance in neuroblastoma
Researchers at Lund University in Sweden have identified one of the reasons why the childhood cancer neuroblastoma becomes resistant to...
Nov 11, 2022
McMaster University researchers pinpoint potential treatment for lethal childhood cancer
An enzyme that drives the growth of an often-lethal childhood brain cancer may hold the key to a future treatment, says a McMaster ...
Nov 10, 2022
Chronic Conditions More Likely Among Survivors of Pediatric Wilms Tumor
Survivors of Wilms tumor are more likely than the general population to experience chronic health conditions, according to a study...
Nov 8, 2022
Changes to chromosomes impact how children’s brain tumours respond to treatment
Every year in the UK, around 55 children are diagnosed with medulloblastoma, and there is a pressing need for new treatments. Now, led...
Nov 7, 2022
‘Chameleon cancers’ change colors to evade treatment, study reveals
Scientists from the Princess Máxima Center for Pediatric Oncology have discovered that some leukemias are capable of altering their...
Nov 4, 2022
Pediatric Multicenter Study Shows Targeted Therapy for High-Risk Hodgkin Lymphoma Reduces Relapse
Children with high-risk Hodgkin lymphoma were 10% less likely to relapse following treatment with brentuximab vedotin combination. Read...